Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

pharmaceutical growth

30.10.2024

Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.

Search the archive

Browse by month